Patients with cancer rarely make clinically inappropriate demands
the ONA take:
According to a new study published in the journal JAMA Oncology, researchers from Abramson Cancer Center and the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, have found that patients rarely push for unnecessary tests and treatments despite physicians' claims that high medical costs are due to patient demands.
For the study, researchers analyzed over 5,000 patient-clinician encounters and found that 440 (8.7%) of those included a patient request or demand for a particular medical medical intervention. Of those, clinicians complied with 365 of the demands after deeming them clinically appropriate.
Of the 50 demands that were not clinically appropriate, clinicians only complied with seven demands. Results showed that 49.1% of demands were for imaging studies, 15.5% for palliative care interventions, 13.6% for laboratory tests, 5.2% for genetic tests, 3.6% for chemotherapy, and less than 1% for proton beam therapy.
In addition, researchers found that patients who had worse relationships with their clinicians and those actively receiving therapy were more likely to make requests or demands.
The findings suggest that patients demands are low and cannot be a key factor of increasing healthcare costs.
Patients rarely push for unnecessary tests and treatments despite physicians' claims that high medical costs are due to patient demands.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|